Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectives
Giulio Rossi,1 Genny Jocollé,2 Antonia Conti,3 Marcello Tiseo,4 Federica Zito Marino,5,6 Giovanni Donati,7 Renato Franco,5,6 Francesca Bono,8 Francesca Barbisan,9 Francesco Facchinetti4,10 1Pathology Unit, 2Oncology Unit, Azienda USL Valle d’Aosta, Regional Hospital “P...
Guardado en:
Autores principales: | Rossi G, Jocollé G, Conti A, Tiseo M, Zito Marino F, Donati G, Franco R, Bono F, Barbisan F, Facchinetti F |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a1ba6c03f55d443a8bc0cfe41a8f2e7e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Small cell transformation in crizotinib‐resistant ROS1‐rearranged non‐small cell lung cancer with retention of ROS1 fusion: A case report
por: Chi‐Hao Wu, et al.
Publicado: (2021) -
Profile of entrectinib and its potential in the treatment of ROS1-positive NSCLC: evidence to date
por: Facchinetti F, et al.
Publicado: (2019) -
Targeting RET-rearranged non-small-cell lung cancer: future prospects
por: Bronte G, et al.
Publicado: (2019) -
Condensed tannin reactivity inhibition by internal rearrangements: Detection by CP-MAS 13C NMR
por: Navarrete,P, et al.
Publicado: (2011) -
Amide-Assisted Rearrangement of Hydroxyarylformimidoyl Chloride to Diarylurea
por: Xizhong Song, et al.
Publicado: (2021)